The Lancet Oncology: November 24, 2014
Charles Bennett discusses the development and regulatory landscape of biosimilar oncology drugs.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology in conversation with
enNovember 24, 2014